Literature DB >> 22260835

Decrease in size of non-treated lesions after cryoablation for hepatocellular carcinoma.

Lin Zhou1, Chun-Ping Wang, Yin-Ying Lu, Wen-Lin Bai, Jian-Hui Qu, Min Lou, Zhen Zeng, Yu Wu, Yan Chen, Hong Wang, Xiu-Juan Chang, Yong-Ping Yang.   

Abstract

We present the case of one 58-year-old man with advancd hepatocellular carcinoma and hepatitis-B virus-related liver cirrhosis who received hepatic cryoablation. Magnetic resonance imaging (MRI) showed multiple liver tumors and the diameter of the largest tumor was more than 10cm. The patient received 2 percutaneous cryoablations in December 2009 and January 2010. Ten months later, MRI showed that not only the treated areas underwent necrosis but also the non-treated area decreased. The a-fetoprotein (AFP) level and the frequency of circulated regulatory T cell (Treg) before treatment were 13,800ng/mL and 15.6%, respectively. Following the cryoablations they dropped to 436ng/mL and 7.6%, respectively, 10 months later. The patient remains in good condition until now.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260835     DOI: 10.5754/hge11182

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.

Authors:  Tim F Greten; Xin W Wang; Firouzeh Korangy
Journal:  Gut       Date:  2015-02-09       Impact factor: 23.059

2.  Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases.

Authors:  Guanghua Rong; Wenlin Bai; Zheng Dong; Chunping Wang; Yinying Lu; Zhen Zeng; Jianhui Qu; Min Lou; Hong Wang; Xudong Gao; Xiujuan Chang; Linjing An; Yan Chen; Yongping Yang
Journal:  Front Med       Date:  2014-07-07       Impact factor: 4.592

3.  Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma.

Authors:  Chun-Ping Wang; Hong Wang; Jian-Hui Qu; Yin-Ying Lu; Wen-Lin Bai; Zheng Dong; Xu-Dong Gao; Guang-Hua Rong; Zhen Zeng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

4.  Targeting and eradicating hepatic cancer cells with a cancer-specific vector carrying the Buforin II gene.

Authors:  Yanyun Wang; Lili Qu; Lailing Gong; Li Sun; Rujun Gong; Jin Si
Journal:  Cancer Biother Radiopharm       Date:  2013-06-25       Impact factor: 3.099

5.  High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma.

Authors:  Yong-Ping Yang; Jian-Hui Qu; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Zheng Dong; Hong Wang; Lin-Jing An; Zhong-Xian Xu; Chun-Ping Wang; Zhen Zeng; Ke-Qin Hu
Journal:  J Transl Med       Date:  2013-02-15       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.